SLC16A3 and cancer: Cancer cells avoid this detrimental effect by promoting the efflux of lactic acid via the H+-coupled monocarboxylate transporters MCT1 (SLC16A1) and MCT4 (SLC16A3), both of which are upregulated in cancer [50,51].